Argireline vs Botulinum Toxin
A side-by-side research comparison of Argireline and Botulinum Toxin across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Argireline | Botulinum Toxin |
|---|---|---|
| Full name | Argireline (Acetyl Hexapeptide-3) | Botulinum Toxin Type A (Botox) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | FDA-approved drug (prescription) |
| Mechanism | Competes with SNAP-25 for position in SNARE complex, partially inhibiting vesicle docking and neurotransmitter release, reducing muscle contraction intensity. | Cleaves SNARE proteins (SNAP-25) required for acetylcholine release at the neuromuscular junction, temporarily blocking nerve signals to targeted muscles. This relaxes the muscle, softening dynamic wrinkles or reducing overactivity. |
| Molecular weight | 889 Da | ~150 kDa |
| Half-life | 8-12 hours (topical) | Effects last ~3-4 months (local) |
| Bioavailability | Moderate (topical) | Local intramuscular/intradermal injection |
| Typical dose | 5-10% solution | Units per treatment area (clinical) |
| Frequency | 2x daily | Every ~3-4 months |
| Route | Topical | Injection by a professional |
Argireline reported benefits
- Reduces expression wrinkles up to 30%
- Non-invasive Botox alternative
- Prevents new wrinkle formation
- No muscle paralysis
- Stackable with other peptides
Botulinum Toxin reported benefits
- Temporarily smooths dynamic wrinkles
- Treats muscle overactivity (medical)
- Reduces excessive sweating (medical)
- Migraine prevention (medical)
Related comparisons
Research and educational reference only. Not medical advice.